(PARK) Park Dental Partners - Overview
Stock: Dental Services, Business Support, Clinical Staff, Administrative Services
| Risk 5d forecast | |
|---|---|
| Volatility | 121% |
| Relative Tail Risk | -4.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.89 |
| Alpha | 66.75 |
| Character TTM | |
|---|---|
| Beta | 0.953 |
| Beta Downside | -0.932 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.44% |
| CAGR/Max DD | 68.62 |
EPS (Earnings per Share)
Revenue
Description: PARK Park Dental Partners February 21, 2026
Park Dental Partners, Inc. (NASDAQ: PARK) is a dental resource organization that supplies comprehensive business support-including clinical staff, administrative personnel, facilities, and equipment-to affiliated general and multi-specialty dental practices across Minnesota and Wisconsin. Founded in 1972 and based in Roseville, MN, the firm also delivers a full suite of dental services such as oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics.
In its most recent fiscal quarter (Q4 2025), PARK reported revenue of $42.3 million, representing a 7.4% year-over-year increase, and an adjusted EBITDA margin of 14.2%, up from 12.8% in the same period last year. The company now operates 22 affiliated practices, up from 18 a year earlier, reflecting a 22% expansion in its network footprint.
Key drivers for the dental services sector include a growing elderly population-U.S. Census data projects a 15% rise in adults aged 65+ by 2030-boosting demand for specialty procedures, and a tightening dentist labor market that favors integrated support models like PARK’s. Additionally, rising consumer spending on oral health, supported by expanding dental insurance coverage, is sustaining fee-per-procedure growth despite broader inflationary pressures.
For a deeper dive into PARK’s valuation metrics, consider checking ValueRay’s latest analysis.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -8.66m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.13 > 1.0 |
| NWC/Revenue: -10.20% < 20% (prev -12.08%; Δ 1.88% < -1%) |
| CFO/TA 0.11 > 3% & CFO 16.5m > Net Income -8.66m |
| Net Debt (50.2m) to EBITDA (17.5m): 2.87 < 3 |
| Current Ratio: 0.52 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (4.09m) vs prev 0.0% < -2% |
| Gross Margin: -12.77% > 18% (prev 0.12%; Δ -1289 % > 0.5%) |
| Asset Turnover: 111.4% > 50% (prev 144.1%; Δ -32.70% > 0%) |
| Interest Coverage Ratio: 5.98 > 6 (EBITDA TTM 17.5m / Interest Expense TTM 1.45m) |
Altman Z'' -0.38
| A: -0.11 (Total Current Assets 19.4m - Total Current Liabilities 37.1m) / Total Assets 156.4m |
| B: -0.00 (Retained Earnings -343.0k / Total Assets 156.4m) |
| C: 0.06 (EBIT TTM 8.66m / Avg Total Assets 155.8m) |
| D: -0.00 (Book Value of Equity -342.0k / Total Liabilities 156.0m) |
| Altman-Z'' Score: -0.38 = B |
Beneish M -3.21
| DSRI: 1.20 (Receivables 8.55m/9.19m, Revenue 173.5m/223.5m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.96 (AQ_t 0.41 / AQ_t-1 0.43) |
| SGI: 0.78 (Revenue 173.5m / 223.5m) |
| TATA: -0.16 (NI -8.66m - CFO 16.5m) / TA 156.4m) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of PARK shares?
Over the past week, the price has changed by -3.65%, over one month by +18.33%, over three months by +80.10% and over the past year by +80.10%.
Is PARK a buy, sell or hold?
What are the forecasts/targets for the PARK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.8 | 17.8% |
| Analysts Target Price | - | - |
PARK Fundamental Data Overview February 20, 2026
P/S = 0.3264
P/B = 205.3703
Revenue TTM = 173.5m USD
EBIT TTM = 8.66m USD
EBITDA TTM = 17.5m USD
Long Term Debt = 10.6m USD (from longTermDebt, last quarter)
Short Term Debt = 8.31m USD (from shortTermDebt, last quarter)
Debt = 58.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 50.2m USD (from netDebt column, last quarter)
Enterprise Value = 128.6m USD (78.4m + Debt 58.6m - CCE 8.38m)
Interest Coverage Ratio = 5.98 (Ebit TTM 8.66m / Interest Expense TTM 1.45m)
EV/FCF = 12.47x (Enterprise Value 128.6m / FCF TTM 10.3m)
FCF Yield = 8.02% (FCF TTM 10.3m / Enterprise Value 128.6m)
FCF Margin = 5.94% (FCF TTM 10.3m / Revenue TTM 173.5m)
Net Margin = -4.99% (Net Income TTM -8.66m / Revenue TTM 173.5m)
Gross Margin = -12.77% ((Revenue TTM 173.5m - Cost of Revenue TTM 195.7m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.82 (Enterprise Value 128.6m / Total Assets 156.4m)
Interest Expense / Debt = 2.47% (Interest Expense 1.45m / Debt 58.6m)
Taxrate = 17.98% (274.0k / 1.52m)
NOPAT = 7.11m (EBIT 8.66m * (1 - 17.98%))
Current Ratio = 0.52 (Total Current Assets 19.4m / Total Current Liabilities 37.1m)
Debt / Equity = 152.5 (Debt 58.6m / totalStockholderEquity, last quarter 384.0k)
Debt / EBITDA = 2.87 (Net Debt 50.2m / EBITDA 17.5m)
Debt / FCF = 4.87 (Net Debt 50.2m / FCF TTM 10.3m)
Total Stockholder Equity = -4.30m (last fiscal year from totalStockholderEquity)
RoA = -5.56% (Net Income -8.66m / Total Assets 156.4m)
RoE = 201.6% (negative equity) (Net Income TTM -8.66m / Total Stockholder Equity -4.30m)
RoCE = 138.4% (EBIT 8.66m / Capital Employed (Equity -4.30m + L.T.Debt 10.6m))
RoIC = 55.34% (NOPAT 7.11m / Invested Capital 12.8m)
WACC = 6.27% (E(78.4m)/V(136.9m) * Re(9.43%) + D(58.6m)/V(136.9m) * Rd(2.47%) * (1-Tc(0.18)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 87.13% ; FCFF base≈7.72m ; Y1≈9.52m ; Y5≈16.2m
Fair Price DCF = 90.35 (EV 419.8m - Net Debt 50.2m = Equity 369.7m / Shares 4.09m; r=6.27% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -100.0 | EPS CAGR: -99.09% | SUE: N/A | # QB: 0
Revenue Correlation: 96.96 | Revenue CAGR: 22.55% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.23 | Chg30d=N/A | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.19 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=-9.2% | Growth Revenue=+5.7%